Mutagenicity of anticancer drugs in mammalian germ cells

被引:110
作者
Witt, KL [1 ]
Bishop, JB [1 ]
机构
[1] OAK RIDGE INST SCI & EDUC, OAK RIDGE, TN 37831 USA
关键词
genetic toxicity; spermatocyte; oocyte; mouse; human risk; mutation;
D O I
10.1016/0027-5107(96)00029-2
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The evidence for mammalian germ cell mutagenicity induced by anticancer drugs is summarized. Primary attention is paid to the three major mouse germ cell mutagenicity tests - the dominant lethal, heritable translocation, and morphological specific locus tests - from which most germ cell mutagenicity data historically have been obtained. Of the 21 anticancer drugs reviewed, 16 have been tested in one or more of these three tests; with all 16 tested in the most common germ cell test, the male dominant lethal test, and 9 of the 16 also tested in the female dominant lethal test. The patterns of germ cell stage specificity for most of the anticancer drugs are similar, and generally resemble the patterns seen with other types of chemicals; however, some of the patterns are unique. For example, 2 of the 8 chemicals shown to induce dominant lethal mutations in female oocytes, do not induce dominant lethal mutations in male germ cells (adriamycin and platinol). Ten of the 16 chemicals tested in the dominant lethal test were positive in post-meiotic stages (spermatids through mature sperm), and seven also induced reciprocal translocations and/or specific locus mutations in post-meiotic stages. This propensity to induce mutations in post-meiotc stages has been observed with most mutagens. However, 5 of the anticancer drugs also induced dominant lethal mutations in spermatocytes (meiotic prophase cells) and one of them, 6-mercaptopurine, uniquely induced dominant lethal mutations exclusively in preleptotene spermatocytes. Finally, three of the anticancer drugs (melphalan, mitomycin C, procarbazine) are members of a very select group of chemicals shown to induce specific locus mutations in spermatogonial stem cells of mice, The implications for human risk are discussed.
引用
收藏
页码:209 / 234
页数:26
相关论文
共 189 条
[11]   MAMMALIAN MALE GERM-CELL CYTOGENETICS [J].
ALBANESE, R .
MUTAGENESIS, 1987, 2 (02) :79-85
[13]   SYNAPTONEMAL COMPLEX DAMAGE AS A MEASURE OF GENOTOXICITY AT MEIOSIS [J].
ALLEN, JW ;
POORMAN, PA ;
BACKER, LC ;
GIBSON, JB ;
WESTBROOKCOLLINS, B ;
MOSES, MJ .
CELL BIOLOGY AND TOXICOLOGY, 1988, 4 (04) :487-493
[14]   SYNAPTONEMAL COMPLEX DAMAGE AS A MEASURE OF CHEMICAL MUTAGEN EFFECTS ON MAMMALIAN GERM-CELLS [J].
ALLEN, JW ;
DEWEESE, GK ;
GIBSON, JB ;
POORMAN, PA ;
MOSES, MJ .
MUTATION RESEARCH, 1987, 190 (01) :19-24
[15]   CYCLOPHOSPHAMIDE - REVIEW OF ITS MUTAGENICITY FOR AN ASSESSMENT OF POTENTIAL GERM-CELL RISKS [J].
ANDERSON, D ;
BISHOP, JB ;
GARNER, RC ;
OSTROSKYWEGMAN, P ;
SELBY, PB .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1995, 330 (1-2) :115-181
[16]   MUTAGENICITY AND CARCINOGENICITY OF TOPOISOMERASE-INTERACTIVE AGENTS [J].
ANDERSON, RD ;
BERGER, NA .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1994, 309 (01) :109-142
[17]   MUTAGENICITY TO SALMONELLA, DROSOPHILA AND THE MOUSE BONE-MARROW OF THE HUMAN ANTINEOPLASTIC AGENT FOTEMUSTINE - PREDICTION OF CARCINOGENIC POTENCY [J].
ASHBY, J ;
VOGEL, EW ;
TINWELL, H ;
CALLANDER, RD ;
SHUKER, DEG .
MUTATION RESEARCH, 1993, 286 (01) :101-109
[18]   THE GENOTOXIC EFFECTS OF ADRIAMYCIN IN SOMATIC AND GERMINAL CELLS OF THE MOUSE [J].
AU, WW ;
HSU, TC .
MUTATION RESEARCH, 1980, 79 (04) :351-361
[19]   MALE GONADAL-FUNCTION AFTER CHEMOTHERAPY FOR SOLID TUMORS IN CHILDHOOD [J].
AUBIER, F ;
FLAMANT, F ;
BRAUNER, R ;
CAILLAUD, JM ;
CHAUSSAIN, JM ;
LEMERLE, J .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) :304-309
[20]   A NEW MUTANT IN THE PROGENY OF MICE TREATED WITH NITROGEN MUSTARD [J].
AUERBACH, C ;
FALCONER, DS .
NATURE, 1949, 163 (4148) :678-679